News

MELBOURNE, Australia, and MONTREAL, Canada – 25 June 2018. Telix Pharmaceuticals has announced a technology...
Read More →
Goetzpartners securities Limited (“Goetzpartners”), a leading pan-European investment bank and research firm, has initiated research...
Read More →
Telix Pharmaceuticals Ltd and ANMI SA will be running a joint user meeting for the...
Read More →
MELBOURNE, Australia – 18 June 2018. Telix Pharmaceuticals today announced that a consortium of industry collaborators,...
Read More →
Telix has selected Goodwin Biotechnology, Inc. to optimize the process for cGMP manufacturing of our renal...
Read More →
The 29:81 (April 2018) edition edition of BioWorld has a very nice little write up on Telix...
Read More →
MELBOURNE, Australia & NANTES, France, 16 April 2018 – Telix announced a research partnership with...
Read More →
MELBOURNE, Australia, 10 April 2018 – Telix Pharmaceuticals is disclosing that a controlled entity of...
Read More →
MELBOURNE Australia, 28 March 2018 – Telix Pharmaceuticals is pleased to provide this update on the...
Read More →
MELBOURNE & INDIANAPOLIS,  26 March 2018 – Telix Pharmaceuticals announced the submission of a Drug...
Read More →